Author:
Dai Meng-Fei,Xin Wen-Xiu,Kong Sisi,Ding Hai-Ying,Fang Luo
Funder
Medical Science and Technology Project of Zhejiang Province
Zhejiang Pharmaceutical Association
Reference33 articles.
1. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020
2. Thrombotic and hemorrhagic incidences in patients after discharge from COVID-19 infection: a systematic review and meta-analysis;Rungjirajittranon;Clin. Appl. Thromb. Hemost.,2021
3. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial;Ramacciotti;Lancet (London, England),2022
4. Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: a systematic review and meta-analysis;Zuin;Thromb. Res.,2022
5. Endothelial cell infection and endotheliitis in COVID-19;Varga;Lancet (London, England),2020
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献